Ignacio Vazquez-Garcia, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Immune Evasion | 1 | 2022 | 377 | 0.630 |
Why?
|
DNA Copy Number Variations | 4 | 2024 | 2045 | 0.470 |
Why?
|
Single-Cell Analysis | 5 | 2025 | 2535 | 0.420 |
Why?
|
Ovarian Neoplasms | 3 | 2022 | 4900 | 0.370 |
Why?
|
Mutation | 8 | 2022 | 30198 | 0.350 |
Why?
|
Saccharomyces cerevisiae | 2 | 2019 | 2674 | 0.340 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2022 | 5337 | 0.330 |
Why?
|
Neoplasms | 8 | 2025 | 22340 | 0.310 |
Why?
|
Cystadenocarcinoma, Serous | 2 | 2022 | 479 | 0.290 |
Why?
|
Genetic Fitness | 3 | 2022 | 119 | 0.260 |
Why?
|
DNA Replication Timing | 1 | 2024 | 35 | 0.230 |
Why?
|
Genome, Mitochondrial | 1 | 2024 | 68 | 0.220 |
Why?
|
Clone Cells | 3 | 2021 | 1672 | 0.210 |
Why?
|
Aneuploidy | 2 | 2024 | 578 | 0.210 |
Why?
|
Evolution, Molecular | 2 | 2022 | 1889 | 0.200 |
Why?
|
Cytostatic Agents | 1 | 2019 | 9 | 0.170 |
Why?
|
Genes, BRCA2 | 1 | 2022 | 588 | 0.160 |
Why?
|
Cytotoxins | 1 | 2019 | 154 | 0.160 |
Why?
|
Genes, BRCA1 | 1 | 2022 | 750 | 0.160 |
Why?
|
Drug Resistance, Fungal | 1 | 2019 | 79 | 0.150 |
Why?
|
DNA, Mitochondrial | 1 | 2024 | 869 | 0.150 |
Why?
|
Genetic Heterogeneity | 1 | 2021 | 735 | 0.140 |
Why?
|
DNA Replication | 2 | 2024 | 1433 | 0.140 |
Why?
|
Genome, Human | 2 | 2020 | 4448 | 0.130 |
Why?
|
Biological Evolution | 2 | 2019 | 1072 | 0.130 |
Why?
|
Genome, Fungal | 1 | 2017 | 204 | 0.130 |
Why?
|
Selection, Genetic | 2 | 2019 | 878 | 0.130 |
Why?
|
Tumor Microenvironment | 2 | 2025 | 3946 | 0.130 |
Why?
|
Cell Nucleus | 1 | 2024 | 2867 | 0.120 |
Why?
|
Genomics | 3 | 2025 | 5929 | 0.120 |
Why?
|
Loss of Heterozygosity | 1 | 2017 | 663 | 0.120 |
Why?
|
Transforming Growth Factor beta | 1 | 2022 | 1995 | 0.120 |
Why?
|
Leukemia, Lymphoid | 1 | 2014 | 307 | 0.110 |
Why?
|
Genomic Instability | 1 | 2017 | 718 | 0.110 |
Why?
|
Asparagine | 1 | 2022 | 120 | 0.100 |
Why?
|
Gene Frequency | 1 | 2017 | 3624 | 0.090 |
Why?
|
Taxoids | 1 | 2022 | 665 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4642 | 0.080 |
Why?
|
Biomedical Research | 1 | 2024 | 3458 | 0.080 |
Why?
|
Cell Line, Tumor | 4 | 2024 | 17075 | 0.080 |
Why?
|
Cell Proliferation | 1 | 2024 | 10429 | 0.080 |
Why?
|
Neoplasm Transplantation | 1 | 2021 | 2014 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3655 | 0.070 |
Why?
|
Cisplatin | 1 | 2021 | 1658 | 0.060 |
Why?
|
Humans | 16 | 2025 | 765968 | 0.060 |
Why?
|
Models, Genetic | 1 | 2014 | 3449 | 0.060 |
Why?
|
Cell Cycle | 2 | 2024 | 2920 | 0.060 |
Why?
|
Phylogeny | 2 | 2022 | 2832 | 0.050 |
Why?
|
Mice | 5 | 2024 | 81819 | 0.050 |
Why?
|
S Phase | 1 | 2024 | 424 | 0.050 |
Why?
|
Models, Biological | 2 | 2019 | 9443 | 0.050 |
Why?
|
Animals | 6 | 2025 | 168764 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2021 | 2942 | 0.040 |
Why?
|
Neoplastic Processes | 1 | 2019 | 35 | 0.040 |
Why?
|
Genes, p53 | 1 | 2022 | 711 | 0.040 |
Why?
|
Diploidy | 1 | 2019 | 141 | 0.040 |
Why?
|
Cell Shape | 1 | 2019 | 373 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2022 | 5783 | 0.040 |
Why?
|
Hydroxyurea | 1 | 2019 | 284 | 0.040 |
Why?
|
Chromosomes, Human | 1 | 2019 | 437 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13451 | 0.040 |
Why?
|
Mutagenesis, Insertional | 1 | 2020 | 661 | 0.030 |
Why?
|
Models, Statistical | 1 | 2021 | 5089 | 0.030 |
Why?
|
DNA Transposable Elements | 1 | 2019 | 765 | 0.030 |
Why?
|
DNA, Neoplasm | 1 | 2021 | 1742 | 0.030 |
Why?
|
Gene Dosage | 1 | 2020 | 1216 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 1 | 2020 | 1061 | 0.030 |
Why?
|
Female | 5 | 2022 | 396112 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2021 | 1751 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2024 | 4772 | 0.030 |
Why?
|
Transcription Factors | 1 | 2022 | 12131 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2022 | 2589 | 0.030 |
Why?
|
Sirolimus | 1 | 2019 | 1545 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2021 | 16047 | 0.020 |
Why?
|
Mitochondria | 1 | 2024 | 3673 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2019 | 2140 | 0.020 |
Why?
|
DNA Repair | 1 | 2020 | 2048 | 0.020 |
Why?
|
Cell Survival | 1 | 2019 | 5747 | 0.020 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2019 | 1833 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2019 | 2878 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3564 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2019 | 3430 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2014 | 21056 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4752 | 0.020 |
Why?
|
Genotype | 1 | 2019 | 13024 | 0.010 |
Why?
|
Genetic Variation | 1 | 2020 | 6610 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20124 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13632 | 0.010 |
Why?
|
Risk Assessment | 1 | 2022 | 24282 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13648 | 0.010 |
Why?
|
Algorithms | 1 | 2014 | 14071 | 0.010 |
Why?
|
Male | 1 | 2019 | 363698 | 0.000 |
Why?
|